Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Head & Neck 1Endocrine 1

Conditions

Neuroendocrine Tumors 73Carcinoma, Neuroendocrine 27Pheochromocytoma 24Thyroid Cancer, Papillary 23Thyroid Neoplasms 21Pituitary Neoplasms 21Adrenocortical Carcinoma 19Paraganglioma 16Multiple Endocrine Neoplasia Type 1 14Neuroblastoma 12Sarcoma 11Adenoma, Islet Cell 11Small Cell Lung Carcinoma 10Neoplasms 10Melanoma 10Lung Neoplasms 9Carcinoid Tumor 9Adrenal Gland Neoplasms 9Adenocarcinoma, Follicular 9Pancreatic Neoplasms 8Gastro-enteropancreatic neuroendocrine tumor 8Carcinoma, Non-Small-Cell Lung 8Carcinoma, Medullary 8Thyroid Carcinoma, Anaplastic 7Neoplasm Metastasis 7Mesothelioma 7Cushing Syndrome 7Cholangiocarcinoma 7Central Nervous System Neoplasms 7Breast Neoplasms 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thyroid cancer, medullary × Endocrine × 90 days × Clear all
NCT02088645 2026-05-01

Lumed

University Hospital, Basel, Switzerland

Phase 1 Active not recruiting
24 enrolled
EndocrineHead & NeckNET

Thyroid cancer, medullary, Carcinoma, Medullary, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡